Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose

NCT01263028 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped Strong enrollment efforts resulted in few eligible subjects and high screen failures due to CKD patients with higher vitamin D levels than anticipated.

Conditions

Interventions

Sponsor

Kaiser Permanente